Shenzhen Neptunus Interlong Bio-technique Company Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CNY 255.81 million compared to CNY 223.17 million a year ago. Net income was CNY 13.62 million compared to CNY 9.8 million a year ago. Basic earnings per share from continuing operations was CNY 0.0081 compared to CNY 0.0058 a year ago.
For the six months, sales was CNY 555.53 million compared to CNY 438.87 million a year ago. Net income was CNY 29.88 million compared to CNY 20.34 million a year ago. Basic earnings per share from continuing operations was CNY 0.0178 compared to CNY 0.0121 a year ago.